Age
Item
subject must be 18 years of age or older
boolean
C0001779 (UMLS CUI [1])
Bare metal stent Implantation
Item
bare metal stent implantation
boolean
C2825200 (UMLS CUI [1,1])
C0021107 (UMLS CUI [1,2])
Patient Discharge Antiplatelet therapy Combined
Item
discharged with dual antiplatelet therapy for at least 60 days
boolean
C0030685 (UMLS CUI [1,1])
C1096021 (UMLS CUI [1,2])
C0205195 (UMLS CUI [1,3])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Study Subject Participation Status Unwilling
Item
patients who do not consent to participate in the study
boolean
C2348568 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
Premenopausal state Contraceptive methods Lacking | Premenopausal state Pregnancy test negative Lacking
Item
premenopausal women not using contraceptive methods or without a negative pregnancy test in the past week
boolean
C0232969 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0232969 (UMLS CUI [2,1])
C0427780 (UMLS CUI [2,2])
C0332268 (UMLS CUI [2,3])
Oral anticoagulants | Oral anticoagulants Planned
Item
patients treated or planned to be treated with oral anticoagulants
boolean
C0354604 (UMLS CUI [1])
C0354604 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
PPI therapy | H2 receptor antagonist therapy | Indication PPI therapy | Indication H2 receptor antagonist therapy
Item
present treatment with or clear indication for treatment with a ppi or h2 antagonists
boolean
C1541225 (UMLS CUI [1])
C0338238 (UMLS CUI [2])
C3146298 (UMLS CUI [3,1])
C1541225 (UMLS CUI [3,2])
C3146298 (UMLS CUI [4,1])
C0338238 (UMLS CUI [4,2])
Hypersensitivity Investigational New Drugs | Intolerance to Investigational New Drugs | Ranitidine allergy | Proton pump inhibitor allergy | Atorvastatin allergy | Hypersensitivity Rosuvastatin | Aspirin allergy | Hypersensitivity Clopidogrel | Intolerance to Ranitidine | Intolerance to Proton Pump Inhibitors | Intolerance to Atorvastatin | Intolerance to Rosuvastatin | Intolerance to Aspirin | Intolerance to Clopidogrel
Item
allergy or intolerance to study medications including ranitidine, proton pump inhibitors, atorvastatin, rosuvastatin, aspirin and/or clopidogrel
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0570577 (UMLS CUI [3])
C0570578 (UMLS CUI [4])
C4274308 (UMLS CUI [5])
C0020517 (UMLS CUI [6,1])
C0965129 (UMLS CUI [6,2])
C0004058 (UMLS CUI [7])
C0020517 (UMLS CUI [8,1])
C0070166 (UMLS CUI [8,2])
C1744706 (UMLS CUI [9,1])
C0034665 (UMLS CUI [9,2])
C1744706 (UMLS CUI [10,1])
C0358591 (UMLS CUI [10,2])
C1744706 (UMLS CUI [11,1])
C0286651 (UMLS CUI [11,2])
C1744706 (UMLS CUI [12,1])
C0965129 (UMLS CUI [12,2])
C1744706 (UMLS CUI [13,1])
C0004057 (UMLS CUI [13,2])
C1744706 (UMLS CUI [14,1])
C0070166 (UMLS CUI [14,2])
Pharmaceutical Preparation Interaction CYP2C19
Item
patient treated with a strong cyp2c19 interacting drug
boolean
C0013227 (UMLS CUI [1,1])
C1704675 (UMLS CUI [1,2])
C3714749 (UMLS CUI [1,3])
Abnormal bleeding
Item
history of a bleeding diathesis, or evidence of active abnormal bleeding within 30 days before enrollment
boolean
C1458140 (UMLS CUI [1])
Intracranial Hemorrhages | Intracranial surgery
Item
history of intracranial hemorrhage or intracranial surgery in the last 3 months
boolean
C0151699 (UMLS CUI [1])
C0745377 (UMLS CUI [2])
Gastrointestinal ulcer
Item
history of gastro-intestinal ulcers in the last 3 months
boolean
C0237938 (UMLS CUI [1])
Illness Serious Influence Therapeutic procedure | Condition Influence Therapeutic procedure
Item
any serious illness or any condition that the investigator feels would influence the impact of this therapy on the subject
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C4054723 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0348080 (UMLS CUI [2,1])
C4054723 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Platelet Count measurement
Item
known platelet count < 100000/mm3 at time of enrollment or within 24 hours prior to enrollment
boolean
C0032181 (UMLS CUI [1])